** Shares of Mach7 Technologies M7T.AX extend gains from the previous session to climb 8% to A$0.4
** Stock hits highest level since Nov 5, 2024
** The medical imaging systems provider posts contracted annual recurring revenue $(CARR)$ of A$31.8 mln ($19.76 mln) at Dec 31, up 15.6% from Sept 2024 levels
** Co reaffirms FY25 outlook for 15-25% growth in CARR
** Co announced on-market buyback programme of up to A$5 mln on Thursday
** About 1.1 mln shares change hands, 2.5 times the 30-day average of share
** Stock down 7.5% this year, as of last close
($1 = 1.6095 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.